VMI

VHCP Management III Portfolio holdings

AUM $504M
This Quarter Return
+50.19%
1 Year Return
+678.37%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$132M
AUM Growth
–
Cap. Flow
+$132M
Cap. Flow %
100%
Top 10 Hldgs %
98.61%
Holding
13
New
13
Increased
–
Reduced
–
Closed
–

Top Buys

1
KALV icon
KalVista Pharmaceuticals
KALV
$28.4M
2
BCRX icon
BioCryst Pharmaceuticals
BCRX
$23.4M
3
OBSV
ObsEva SA Ordinary Shares
OBSV
$20.9M
4
TCDA
Tricida, Inc. Common Stock
TCDA
$19.9M
5
ECYT
Endocyte, Inc. Common Stock
ECYT
$10.7M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 92.69%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KALV icon
1
KalVista Pharmaceuticals
KALV
$678M
$28.4M 21.47%
+1,284,931
New +$28.4M
BCRX icon
2
BioCryst Pharmaceuticals
BCRX
$1.74B
$23.4M 17.65%
+3,061,091
New +$23.4M
OBSV
3
DELISTED
ObsEva SA Ordinary Shares
OBSV
$20.9M 15.8%
+1,159,789
New +$20.9M
TCDA
4
DELISTED
Tricida, Inc. Common Stock
TCDA
$19.9M 15.02%
+650,585
New +$19.9M
ECYT
5
DELISTED
Endocyte, Inc. Common Stock
ECYT
$10.7M 8.05%
+600,000
New +$10.7M
KNSA icon
6
Kiniksa Pharmaceuticals
KNSA
$2.48B
$8.36M 6.32%
+327,777
New +$8.36M
KDMN
7
DELISTED
Kadmon Holdings, Inc.
KDMN
$7.98M 6.03%
+2,388,572
New +$7.98M
MRNS
8
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$6.72M 5.08%
+672,271
New +$6.72M
BLPH
9
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$2.46M 1.86%
+2,274,370
New +$2.46M
MTVA
10
MetaVia Inc. Common Stock
MTVA
$15.3M
$1.79M 1.35%
+869,538
New +$1.79M
APLS icon
11
Apellis Pharmaceuticals
APLS
$3.48B
$894K 0.68%
+50,290
New +$894K
CCXI
12
DELISTED
ChemoCentryx, Inc.
CCXI
$493K 0.37%
+39,036
New +$493K
CNST
13
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$449K 0.34%
+66,667
New +$449K